ArticlePDF Available

Gender-Specific Associations of Serum Antibody to Porphyromonas gingivalis and Inflammatory Markers

Wiley
BioMed Research International
Authors:

Abstract and Figures

It remains unclear whether serum antibody titer against Porphyromonas gingivalis (Pg) and inflammatory components lead to periodontal deterioration in each gender, as periodontal and systemic status is influenced by gender. The present study investigates the gender-specific probable effects of titer against Pg and inflammatory markers on periodontal health status in a longitudinal study. A retrospective study design was used. At two time points over an 8-year period (in 2003 and 2011), 411 individuals (295 males with a mean age of 57.6 ± 11.2 years and 116 females with a mean age of 59.2 ± 10.3 years) were surveyed. Periodontal status, serum antibody titer against Pg, and high-sensitive C-reactive protein (hsCRP) were evaluated. Poisson regression analyses revealed that the elevated titer against Pg and hsCRP significantly predicted the persistence of periodontal disease 8 years later in females with periodontal disease in 2003. Elevated hsCRP was significantly associated with the incidence of periodontal disease 8 years later in females who were periodontally healthy in 2003. Males had a weaker association among titer against Pg, inflammatory markers, and periodontal disease. These findings suggest that immune response to Pg infection in addition to inflammatory components affects periodontal deterioration in females.
This content is subject to copyright. Terms and conditions apply.
Research Article
Gender-Specific Associations of Serum Antibody to
Porphyromonas gingivalis and Inflammatory Markers
Michiko Furuta,1Yoshihiro Shimazaki,1,2 Shunichi Tanaka,3Kenji Takeuchi,1
Yukie Shibata,1Toru Takeshita,1Fusanori Nishimura,4and Yoshihisa Yamashita1
1Section of Preventive and Public Health Dentistry, Division of Oral Health, Growth and Development,
Kyushu University Faculty of Dental Science, Fukuoka 812-8582, Japan
2Department of Preventive Dentistry and Dental Public Health, School of Dentistry, Aichi-Gakuin University, Nagoya 464-8650, Japan
3Japanese Red Cross Kumamoto Healthcare Center, Kumamoto 861-8528, Japan
4Section of Periodontology, Division of Oral Rehabilitation, Kyushu University Faculty of Dental Science, Fukuoka 812-8582, Japan
Correspondence should be addressed to Yoshihisa Yamashita; yoshi@dent.kyushu-u.ac.jp
Received  October ; Revised  December ; Accepted  December 
Academic Editor: Kazuhiko Nakano
Copyright ©  Michiko Furuta et al. is is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
It remains unclear whether serum antibody titer against Porphyromonas gingivalis (Pg) and inammatory components lead to
periodontal deterioration in each gender, as periodontal and systemic status is inuenced by gender. e present study investigates
the gender-specic probable eects of titer against Pg and inammatory markers on periodontal health status in a longitudinal
study. A retrospective study design was used. At two time points over an -year period (in  and ),  individuals (
males with a mean age of . ±. years and  females with a mean age of . ±. years) were surveyed. Periodontal status,
serum antibody titer against Pg, and high-sensitive C-reactive protein (hsCRP) were evaluated. Poisson regression analyses revealed
that the elevated titer against Pg and hsCRP signicantly predicted the persistence of periodontal disease years later in females
with periodontal disease in . Elevated hsCRP was signicantly associated with the incidence of periodontal disease years later
in females who were periodontally healthy in . Males had a weaker association among titer against Pg, inammatory markers,
and periodontal disease. ese ndings suggest that immune response to Pg infection in addition to inammatory components
aects periodontal deterioration in females.
1. Introduction
Oral diseases limit an individual’s capacity in biting, chewing,
smiling, speaking, and psychosocial wellbeing []. e most
common oral diseases are dental caries and periodontal
disease. Periodontal disease, that is, inammatory disorder of
the gingiva, is highly prevalent around the world, and nearly
% of adults have periodontal disease [].
As with many chronic diseases, periodontal disease has
multiple risk factors, and it is important to treat both the local
and systemic factors []. Among local factors for periodontal
disease, it has been recognized that periodontal disease is
caused by specic bacteria in the periodontal pocket [].
Porphyromonas gingivalis (Pg) plays a major role in the path-
ogenesis of periodontal disease and is considered to induce
elevated systemic and local immune responses in periodontal
patients [,]. Elevated serum IgG antibody levels of Pg
have previously been reported to be closely connected to
thepresenceofPg in periodontal pockets [,], reecting
the notion that serum antibody titers against Pg are higher
in periodontal patients than in healthy individuals [].
Most previous studies have been cross-sectional or short-
term longitudinal in design and such designs do not provide
information or are decient in information on the long-term
association between serum antibody titers against Pg and
periodontal status.
Periodontal disease is a local inammatory condition
and is linked to systemic inammation via host responses.
Several cross-sectional studies have reported that levels of
inammatory markers are higher in patients with periodontal
Hindawi Publishing Corporation
BioMed Research International
Volume 2015, Article ID 897971, 9 pages
http://dx.doi.org/10.1155/2015/897971
BioMed Research International
2,470 individuals who visited the Japanese Red Cross Kumamoto Healthcare Center for
medical check-ups in 2011 and had the earliest check-ups between 2003 and 2006.
Group 1:468 visited in 2003 and 2011. Serum samples collected in 2003 were preserved.
Group 2:945 visited in 2004 and 2011.
Group 3:832 visited in 2005 and 2011.
Group 4:225 visited in 2006 and 2011.
e design of this study was explained to group 1in 2011.
447 were obtained informed consent for the use of preserved serum samples.
Participation rate: 96%
Exclusion
19 with insucient serum
sample volume.
14 with fewer than ten teeth.
3with missing value.
Analysis: 411 participants (296 males, 118 females).
Exclusion
Groups 2,3, and 4
F : Flow diagram of study participant selection.
diseasethaninhealthyindividuals[,]. Systemic inam-
mation accompanies chronic inammatory diseases such as
cardiovascular disease, diabetes, and metabolic syndrome
[], and thus systemic inammation is suggested to be an
underlying risk factor in periodontal disease as a localized
inammatory disease.
As another risk factor for periodontal disease, gender is
an important consideration, because periodontal disease is
oen reported to be more prevalent or severe in males than
in females [,,] and associations between periodontal
disease and metabolic syndrome have been conrmed in
females but not in males []. us, the association between
periodontal disease and local and systemic risk factors may
also be expected to have gender dierences. However, most
studies have not considered this hypothesis and did not
use stratied analysis, which would allow determination of
whether the relationship is unique to one gender, or even
opposite in males and females. In this study, we investigated
the gender-specic probable eects of titer against Pg and
inammatory markers on periodontal status in a longitudinal
study, as it remains unclear whether these factors lead to
gender-specic periodontal deterioration.
2. Materials and Methods
2.1. Study Participants. We performed a retrospective study.
Participants were recruited from among , individuals
who visited the Japanese Red Cross Kumamoto Healthcare
Center, Kumamoto, Japan, for periodic medical check-ups
including dental examination in  and had the earliest
check-ups between  and . e , individuals
were categorized into four groups:  visited in  and
 (group ),  visited in  and  (group ), 
visited in  and  (group ), and  visited in 
and  (group ). In group , serum samples collected in
 for another study had been preserved. e design of
this study using preserved serum samples for measurement
of titers against Pg and high-sensitive C-reactive protein
(hsCRP) was explained to  individuals (group ) and
written informed consent was obtained from  individuals
(participation rate, %). Nineteen participants with insu-
cient serum sample volume were excluded. We also excluded
 participants with missing value and fewer than  teeth due
to diculties in assessing their current periodontal health
properly []. erefore,  participants ( males with a
mean age of 57.6 ±11.2 years and  females with a mean age
of 59.2 ± 10.3 years) were analyzed in this study. Participant
ow diagram is presented in Figure .
e study was approved by Kyushu University Institu-
tional Review Board for Clinical Research (-).
2.2. Oral and General Examinations and Questionnaire. One
dentist (ST) assessed the oral health status of participants
in both  and . e number of teeth present was
determined. According to the World Health Organization
Community Periodontal Index (CPI) criteria []withmod-
ication, periodontal condition was assessed in all present
teeth to monitor the periodontal health. e highest CPI
codes were recorded in each sextant. Periodontal disease
was dened as at least one sextant with the presence of
periodontal pocket depth mm(CPIcode) [].
Overweight was dened as body mass index (BMI) of .
or greater. A venous blood sample was drawn and analyzed
BioMed Research International
for fasting glucose, triglycerides, high density lipoprotein
(HDL) cholesterol, leukocyte count, and dierential leuko-
cyte count (i.e., neutrophils, acidocytes, and monocytes).
Elevated levels of fasting glucose, triglycerides, HDL, and
blood pressure were dened by the Joint Interim Societies
[]. Elevated leukocytes were dened as white blood cell
of . ×9/L []. In the present study, we measured
hsCRP in preserved serum samples in . HsCRP levels of
. mg/L were dened as elevated hsCRP []. CRP levels
tend to increase with acute bacterial and viral infections,
age, smoking, myocardial infarction, rheumatoid arthritis,
obesity, type diabetes, hypertension, and cancer []. We
considered the eect of these factors on hsCRP in analysis.
Information on smoking habit, alcohol consumption, and
toothbrushing frequency was obtained by a self-administered
questionnaire. Smokers were categorized as never smokers,
who had never smoked regularly; past smokers, who had
smoked regularly but had stopped smoking more than one
year ago; and current smokers, who had smoked regularly.
Alcohol drinkers were categorized as either current drinker,
who had drunk at least one time per week, or not current
drinkers. Toothbrushing frequency was categorized as either
more than three times daily toothbrushing or not.
2.3. Measurement of Titers against Pg. e immunological
assays used in this study were as described previously [,].
Serum IgG antibody titers against Pg (FDC) were deter-
mined by Leisure Inc. (Tokyo, Japan) using enzyme-linked
immunosorbent assay (ELISA) from serum samples stored
at –C. e absorbance of each sample was evaluated and
assigned ELISA unit (EU) values relative to the absorbance
of a pool of sera collected from periodontally healthy control
individuals []. Pg antibody levels are expressed as standard-
ized values calculated as follows: (EU for study serum samples
EU for control samples)/ ×(SD of control samples) [].
An elevated serum antibody titer against Pg was dened as
having a value greater than median value [].
2.4. Statistical Analysis. Chi-squared test for categorical data
and Mann-Whitney Utest for continuous data were used
to determine signicant dierences (𝑃 < 0.05, two sided)
between males and females or to elevate the associations
between periodontal disease, titer against Pg,andinam-
matory markers. e multivariate associations among them
were examined in Poisson regression models as follows: ()
model with periodontal disease in  as a dependent
variable, using cross-sectional data in  and () model
with periodontal disease at follow-up as a dependent variable,
using longitudinal data. In the second model, titer against Pg
and inammatory markers were entered as independent vari-
ables. HsCRP, leukocytes, and BMI were treated as inam-
matory markers, because obesity may be linked to chronic
inammation. As potential confounders, age, toothbrushing
frequency, and smoking were included in the model because
they are known to increase the risk of periodontal disease
[]. Fasting glucose, triglycerides, HDL, and blood pressure
were also included in the model, because they are possible to
be associated with inammatory markers. Prevalence ratios
(PRs) and % condence intervals (CIs) were calculated.
SPSS soware (version . for Windows; IBM SPSS Japan,
Tokyo, J a p a n ) w a s u sed for d at a a n a l y s es.
3. Results
e percentage of participants having periodontal disease
was .% in . Oral and systemic health status in 
and  is shown in Ta b l e . ere were gender dierences in
the number of the present teeth, smoking habit, toothbrush-
ing frequency, and alcohol consumption. Serum antibody
titer against Pg and hsCRP did not show a gender dierence.
Among the  data, the associations of periodontal disease
with titer against Pg andwithsystemichealthareshown
in Table .WhenthePoissonregressionmodelincluded
covariates with a signicance level for retention of 𝑃 < 0.2
on bivariate analysis, high titer against Pg was signicantly
associated with the periodontal disease in both males and
females. In females, overweight was signicantly associated
with periodontal disease.
Among longitudinal data, periodontal disease persisted
years later in .% of males with periodontal disease
in  and .% of females with periodontal disease in
 had persistent periodontal disease years later (Tabl e ).
Among periodontally healthy males in , .% devel-
oped periodontal disease years later, while, for females,
.% developed periodontal disease years later. When we
evaluated the association between hsCRP and possible related
factors, such as fasting glucose, triglycerides, HDL, blood
pressure, and leukocytes, these factors were signicantly
associated with hsCRP. Acute bacterial and viral infections
(𝑛=0), myocardial infarction (𝑛=1), rheumatoid arthritis
(𝑛=1), and cancer (𝑛=21)werenotassociatedwithhsCRP.
PoissonregressionanalysesshowedthatlevelsofhsCRPwere
signicantly related to development of periodontal disease
yearslaterinperiodontallyhealthyfemalesin(PR.;
% CI: .–.; 𝑃value .), even when age, smoking,
toothbrushing frequency, and possible hsCRP-related factors
were included in the model (Model in Tab l e ). Leukocytes
count was not associated with periodontal disease. Persis-
tence of periodontal disease years later in females was
signicantly associated with antibody titer against Pg (PR
.; % CI: .–.; 𝑃value .) and hsCRP (PR .;
% CI: .–.; 𝑃value .). e interaction between Pg
and hsCRP was not statistically signicant. To conrm the
consistency of the results, we treated antibody titer against
Pg as a categorical variable (Model in Tab l e ). ese
associations were not signicant in males.
When the association between titer against Pg in  and
systemic health such as lower HDL, elevated triglycerides,
and blood pressure years later was examined, the associa-
tion was not signicant.
4. Discussion
is study showed gender-specic associations of periodon-
tal status with serum titer against Pg and with inammatory
markers in a long-term longitudinal study. Serum titer against
BioMed Research International
T : Characteristics of study subjects in  and .
Variabl e s
 
Males
(𝑛=)
Females
(𝑛=) All 𝑃value Males
(𝑛=)
Females
(𝑛=) All 𝑃value
e number of the present
teeth (median [%, %]) (, )  (, )  (, ) .  (, )  (, )  (, ) .
Periodontal dis ease (PD
mm) (%) . . . . . . . .
Serum antibody titer against
𝑃𝑔. (., .) . (., .) . (., .) .
Age (median [%, %])  (, )  (, )  (, ) .  (, )  (, )  (, ) .
More than times daily
toothbrushing . . . <.
Current/past smoking (%) . . . <. . . . <.
Current alcohol consumption
(%). . . <. . . . <.
Overweight (%) . . . . . . . .
Elevated hsCRP (mg/L)
(%). . . .
Elevated fasting glucose
( mg/dL) (%) . . . . . . . .
Reduced HDL (males <,
females < mg/dL) (%). . . . . . . .
Elevated triglycerides
( mg/dL) (%)§. . . . . . . .
Elevated blood pressure
(/ mmHg) (%). . . . . . . .
Elevated leukocytes (. ×
cells/L) (%) . . . . . .
Leukocytes (median [%,
%])(
cells/L) . (., .) . (., .) . (., .) . . (., .) . (., .) . (., .) .
Neutrophils (median [%,
%])(
cells/L) . (., .) . (., .) . (., .) . . (., .) . (., .) . (., .) .
Acidocytes (median [%,
%])(
cells/L)
. (.,
.)
. (.,
.)
. (.,
.) . . (.,
.)
. (.,
.)
. (.,
.) <.
Monocytes (median [%,
%])(
cells/L)
. (.,
.)
. (.,
.)
. (.,
.) <. . (.,
.)
. (.,
.)
. (.,
.) <.
Serum antibody titer against 𝑃𝑔 and hsCRP were measured in preserved serum samples in .
Males, 𝑛= ; females, 𝑛= , in .
HDL < mg/dL in males and < mg/dL in females for reduced HDL.
§Triglycerides mg/dL or drug treatment for dyslipidemia.
Systolic blood pressure  mmHg or diastolic blood pressure  mmHg or antihype rtensive d rug treat ment.
PD, periodontal pocket depth; hsCRP, high-sensitive C-reactive protein; HDL, high-density lipoprotein cholesterol.
Pg and inammatory markers showed a stronger association
with periodontal status in females than in males. To the best
ofourknowledge,thisistherststudytoshowsuchgender
dierences in a longitudinal study.
In this study, we found that serum titer against Pg was
high in participants with periodontal disease at a single time
point, based on cross-sectional data in . is nding
is consistent with several studies []. Ebersole et al. []
noted that elevated systemic antibodies against periodon-
tal bacteria were reective of subgingival colonization and
existed as a response to bacterial infection at disease-active
sites. ese results suggest that elevated antibody levels
against Pg areassociatedwithpriordestructiveperiodontal
disease [].
In addition, high titer against Pg inuenced the persis-
tence of periodontal disease over the -year period in females
with periodontal disease at baseline, based on longitudinal
data analyses. is nding is similar to the data of Craig
et al. [], who reported that individuals with progressed
periodontaldiseasehadheightenedserumantibodyresponse
to Pg at baseline. Anderson et al. []observedthatthe
IgG antibody against Pg produced in response to progressing
periodontal disease appeared to lack functional properties
such as direct cytolysis and opsonization in nonhuman
BioMed Research International
T : Prevalence ratios for periodontal disease (presence of periodontal pocket depth mm) in  in males and females.
Covariates from data of 
Males Females
Number of those
having periodontal
disease
(𝑛=)
Crude PR
(% CI)
Adjusted PR
(% CI)
Number of
those having
periodontal
disease
(𝑛=)
Crude PR
(% CI)
Adjusted PR
(% CI)
Serum antibody titer against
Pg (%)
Low  (.)  (.)
High  (.) . (.–.)∗∗∗ . (.–.)∗∗∗  (.) . (.–.)∗∗∗ . (.–.)∗∗
Overweight
No  (.)  (.)
Yes  (.) . (.–.)  (.) . (.–.)∗∗∗ . (.–.)
hsCRP
Normal  (.)  (.)
Elevated hsCRP  (.) . (.–.)  (.) . (.–.) . (.–.)
Leukocytes . (.–.) . (.–.)
Fasting glucose
Normal  (.) (.)
Elevated fasting glucose  (.) . (.–.)  (.) . (.–.)
HDL
Normal  (.)  (.)
Reduced (.) . (.–.) (.)
Triglycerides
Normal  (.)  (.)
Elevated triglycerides  (.) . (.–.)  (.) . (.–.)
Blood pressure
Normal  (.)  (.)
Elevated blood pressure  (.) . (.–.)  (.) . (.–.)
Age
< yrs  (.)  (.)
 yrs  (.) . (.–.)∗∗ . (.–.)∗∗  (.) . (.–.)
Toothbrushing frequency
< times/day  (.)  (.)
times/day  (.) . (.–.)  (.) . (.–.)
Smoking
Never  (.)  (.)
Current/Past  (.) . (.–.) . (.–.) (.) . (.–.)
Alcohol consumption
No  (.)  (.)
Current  (.) . (.–.)  (.) . (.–.)
Poisson regression analysis with periodontal disease (periodontal pocket depth mm) in  as the dependent variable and serum antibody titer against Pg,
overweight, hsCRP, leukocytes fasting glucose, HDL, triglycerides, blood pressure, age, smoking, and drinking in  as the independent variables.
𝑃<., ∗∗𝑃<., and ∗∗∗𝑃<..
Adjusted prevalence ratios in the nal multivariable model aer including covariates with a signicance level for retention of 𝑃<..
PR was not calculated because of complete separation (the number of females with periodontally healthy and reduced HDL was ).
HsCRP, high-sensitive C-reactive protein; HDL, high-density lipoprotein cholesterol; PR, prevalence ratio; CI, condence interval.
BioMed Research International
T : Changes in periodontal disease between  and .
Variabl e s
from data of 
Periodontally healthy in  Periodontal disease in 
Males Females Males Females
In  In  In  In 
Healthy Periodontal
disease Healthy Periodontal
disease Healthy Periodontal
disease Healthy Periodontal
disease
𝑛=  𝑛= 𝑛= 𝑛= 𝑛= 𝑛= 𝑛= 𝑛=
Serum antibody titer
against 𝑃𝑔†‡ .
(., .)
.
(., .)
.
(., .)
.
(., .)
.
(., .)
.
(., .)
.
(., .)
.
(., .)
High serum antibody
level (.) to Pg (%). . . . . . . .
Overweight (%). . . . . .. .
Elevated hsCRP
(.) (%). . . .5∗∗ . . . .5∗∗
Leukocytes (
cells/L)§. (., .) . (., .) . (., .) . (., .) . (., .) . (., .) . (., .) . (., .)
𝑃<., ∗∗𝑃<..
Median (%, %).
Comparison between participants with or without periodontal disease in  by bivariate analysis.
§Continuous variable of leukocytes was used, because of small number of elevated leukocytes (. ×cells/L).
HsCRP, high-sensitive C-reactive protein.
T : Prevalence ratios for periodontal disease in .
Periodontally healthy in  Periodontal disease in 
Males Females Males Females
PR (% CI)PR (% CI)PR (% CI)PR (% CI)
Model 1
Serum antibody titer against Pg . (.–.) . (.–.) . (.–.) . (.–.)∗∗
Overweight
No
Yes . (.–.) . (.–.) . (.–.) . (.–.)
hsCRP
Normal
Elevated hsCRP . (.–.) . (.–.)∗∗ . (.–.) . (.–.)
Leukocytes. (.–.) . (.–.) . (.–.) . (.–.)
Model 2
Serum antibody titer against Pg
Low
High . (.–.) . (.–.) . (.–.) . (.–.)
Overweight
No
Yes . (.–.) . (.–.) . (.–.) . (.–.)
hsCRP
Normal
Elevated hsCRP . (.–.) . (.–.)∗∗ . (.–.) . (.–.)
Leukocytes. (.–.) . (.–.) . (.–.) . (.–.)
Dependent variable, : periodontal disease in , : periodontally healthy in .
Model : continuous variable of serum antibody titer against Pg was included.
Model : categorical variable of serum antibody titer against Pg was included.
𝑃<., ∗∗𝑃<..
Adjusted by age, smoking, toothbrushing frequency, triglycerides, HDL, fasting glucose, and systolic blood pressure in .
Continuous variable of leukocytes was used, because of small number of elevated leukocytes.
HsCRP, high-sensitive C-reactive protein; PR, prevalence ratio; CI, condence interval.
BioMed Research International
primates. ey speculated that the antibody response does
not protect against periodontal disease in many patients.
On the other hand, antibody levels to periodontal bacteria
have been reported to remain elevated over a -month
period, despite periodontal therapy []. Although it is
possible that antibody levels against Pg are retained for long
periods, our results suggest that high titers against Pg do not
provide protection against periodontal disease in females, as
compared with males. Generally, antibody plays an important
role in defense against pathogenic bacteria. With regard to
antibody responses against Pg, it has been suggested that
elevated antibody levels are in response to pathogens, but
have little eect on infections []. To determine more about
the exact relationship between antibody level and periodontal
disease in each gender, it will be necessary to repeat the study
in larger numbers of subjects and to assess Pg colonization.
Gender dierences in the longitudinal association
between antibody titer against Pg and periodontal disease
might be explained by disparities in immune responses.
Although sex dierences in immune response remain
incompletely understood, presumably, sex-specic genetic
architecture accounts for dimorphisms in immune response
and host susceptibility, exerting profound eects on
multiple immunologic parameters []. e X-chromosome
encodes approximately , genes, related to immunity
[]. Females have two X-chromosomes, which provides
the added biological advantage of the cellular mosaicism
that is associated with X-inactivation, whereas males are
more vulnerable to X-linked diseases as they have a single
X-chromosome []. Sex dierences in immunity would
be associated with cellular functions dependent on genes
located on the X-chromosome []. We speculate that
protection from periodontal disease by antibody against Pg
diers between males and females, probably due to sexual
dimorphisms in immunoinammatory response that is
inuenced by sex-specic genetic architecture.
When we investigated the association between inamma-
tory markers and progression of periodontal disease, higher
levels of hsCRP were signicantly associated with devel-
opment and persistence of periodontal disease in females,
but not in males. While Paraskevas et al. []reported
strong evidence by meta-analyses of cross-sectional studies
that CRP in periodontal disease was elevated as compared
with healthy individuals, our longitudinal study indicated
gender-specic eects of CRP levels on the progression
of periodontal disease. e dierence in the inammatory
response in females compared to males has long been
noted []. ese dierences by gender may be due to sex
hormone, estrogen. However, this does not provide sucient
evidence because estrogen production seems to diminish in
our female subjects with menopause. Conversely, a lot of
evidences suggest that the declining function of the ovaries in
femalesisassociatedwithspontaneousincreasesinsystemic
proinammatory cytokines [,]. Inammation is known
to cause periodontal disease [,,]. e present results
suggest that the relationship between periodontal disease and
systemic inammation presumably diers by gender because
of the dierences in the inammatory response by gender in
regard to proinammatory cytokine. e exac t mechanism by
which estrogen modulates proinammatory cytokine activity
hasnotyetbeenconclusivelyclaried[,], and further
analyses are needed to fully understand the details of the
mechanism of the interference by estrogen.
ere were several limitations to the current study. We
usedthesamemethodtomeasuretitersagainstPg as reported
by Kudo et al. [], and the percentage of participants with
. titers in our study and the study by Kudo et al.
was % and %, respectively. In addition, when we ana-
lyzed receiver operating characteristics (ROC) curves for
periodontal disease (presenting of PD mm), the optimal
cut-o point of titers against Pg was . (. in Kudo et al.)
and sensitivity, specicity, and the areas under the ROC curve
were ., ., and .. Hence, our participants may
have had higher titers against Pg,ascomparedtothoseinthe
study by Kudo et al. Second, we did not have any information
on oral health behavior such as regular dental visits and
receipt of dental treatment. ese would aect periodontal
status, and thus our ndings could reect confounding by
omitting these variables. ird, we did not measure the sign
of periodontal disease such as clinical attachment loss. It
has been suggested that the elevated antibody levels are in
responsetopathogensandareexpectedtobeinuencedby
the size of the area of infection rather than by the history of
tissue destruction []. At baseline, periodontal pocket depth
would be acceptable in investigating the association between
titers against Pg and periodontal condition. It is not beyond
the realm of possibility that titers against Pg are related to
attachment loss years later. Finally, socioeconomic status
was not included as a factor in this analysis. Future studies
should include this, because it is possible that socioeconomic
status is connected with periodontal and systemic health
status.
Even considering the above limitations, the present study
illustrates that females with high titer against Pg and high
level of inammatory marker are more likely to have peri-
odontal disease some years later, while males have a relatively
weak relationship among the titer against Pg,inammatory
markers, and periodontal disease.
Conflict of Interests
e authors declare that there is no conict of interests
regarding the publication of this paper.
Acknowledgment
is study was supported by Grants-in-Aid for Scientic
Research (, , and ) from the
Ministry of Education, Science, Sports, and Culture of Japan,
Tokyo, J a p a n .
References
[] World Health Organization, Oral Health,,http://www
.who.int/mediacentre/factsheets/fs/en/.
[] B.L.Pihlstrom,B.S.Michalowicz,andN.W.Johnson,“Peri-
odontal diseases, e Lancet,vol.,no.,pp.,
.
BioMed Research International
[] R. J. Genco, Current view of risk factors for periodontal dis-
eases, Journal of Periodontology,vol.,no.,supplement,pp.
–, .
[] J. J. Zambon, “Periodontal diseases: microbial factors, Annals
of Periodontology,vol.,no.,pp.,.
[] A.D.HaajeeandS.S.Socransky,“Microbialetiologicalagents
of destructive periodontal diseases, Periodontolog y 2000,vol.,
pp. –, .
[] J.L.EbersoleandM.A.Taubman,“eprotectivenatureofhost
responses in periodontal diseases., Periodontology 2000,vol.,
pp. –, .
[] T. Kojima, K. Yano, and I. Ishikawa, “Relationship between
serum antibody levels and subgingival colonization of Porphy-
romonas gingivalis in patients with various types of periodon-
titis, Journal of Periodontology,vol.,no.,pp.,.
[] T. Nakagawa, S. Yamada, M. Tsunoda et al., “Clinical, microbio-
logical, and immunological studies following initial preparation
in adult periodontitis, e Bulletin of Tokyo Dental College,vol.
,no.,pp.,.
[] Y. Furuichi, H.-O. Ito, Y. Izumi et al., “Periodontal status and
serum antibody titers for Porphyromonas gingivalis mbriae in
a rural population in Japan, Journal of Clinical Periodontology,
vol. , no. , pp. –, .
[] R. G. Craig, R. Boylan, J. Yip et al., “Serum IgG antibody
response to periodontal pathogens in minority populations:
relationship to periodontal disease status and progression,
Journal of Periodontal Research,vol.,no.,pp.,.
[] C. Kudo, K. Naruishi, H. Maeda et al., Assessment of the plas-
ma/serum IgG test to screen for periodontitis, Journal of Dental
Research,vol.,no.,pp.,.
[] M. I. Fredriksson, C. M. S. Figueredo,A. Gustaf sson, K. G. Berg-
str¨
om, and B. E. ˚
Asman, “Eect of periodontitis and smoking
on blood leukocytes and acute-phase proteins, Journal of
Periodontology, vol. , no. , pp. –, .
[] B.Noack,R.J.Genco,M.Trevisan,S.Grossi,J.J.Zambon,and
E. de Nardin, “Periodontal infections contribute to elevated sys-
temic C-reactive protien level, Journal of Periodontology,vol.
,no.,pp.,.
[] N.Esser,S.Legrand-Poels,J.Piette,A.J.Scheen,andN.Paquot,
“Inammation as a link between obesity, metabolic syndrome
and type diabetes, Diabetes Research and Clinical Practice,vol.
, no. , pp. –, .
[]J.M.Albandar,“Globalriskfactorsandriskindicatorsfor
periodontal diseases, Periodontology 2000,vol.,no.,pp.
–, .
[] M. Furuta, Y. Shimazaki, T. Takeshita et al., “Gender dierences
in the association between metabolic syndrome and periodon-
tal disease: the Hisayama Study, Journal of Clinical Periodontol-
ogy,vol.,no.,pp.,.
[] J. Ainamo, D. Barmes, G. Beagrie, T. Cutress, J. Martin, and J.
Sardo-Inrri, “Development of the World Health Organization
(WHO) community periodontal index of treatment needs
(CPITN), International Dental Journal,vol.,no.,pp.
, .
[] I. Morita, H. Nakagaki, S. Yoshii et al., “Gradients in periodontal
status in Japanese employed males, Jour nal of Clinical Periodon-
tology,vol.,no.,pp.,.
[] K. G. M. M. Alberti, R. H. Eckel, S. M. Grundy et al., “Harmo-
nizing the metabolic syndrome: a joint interim statement of
the international diabetes federationt askforce on epidemiology
and prevention; National Heart, Lung, and Blood Institute;
American Heart Association; World Heart Federation; Inter-
national Atherosclerosis Society ; and International Association
for the Study of Obesity, Circulation,vol.,no.,pp.
, .
[] T. Kawada, “Smoking-induced leukocytosis can persist aer
cessation of smoking,” Archives of Medical Research,vol.,no.
,pp.,.
[] Y. Momiyama, A. Kawaguchi, I. Kajiwara et al., “Prognostic
value of plasma high-sensitivity C-reactive protein levels in
Japanese patients with stable coronary artery disease: the Japan
NCVC-Collaborative Inammation Cohort (JNIC) study,
Atherosclerosis,vol.,no.,pp.,.
[] K. H. Allin and B. G. Nordestgaard, “Elevated C-reactive pro-
tein in the diagnosis, prognosis, and cause of cancer, Critical
Reviews in Clinical Laboratory Sciences,vol.,no.,pp.
, .
[] Y. Murayama, A. Nagai, K. Okamura et al., Serum immuno-
globulin G antibody to periodontal bacteria, Advances in dental
research, vol. , no. , pp. –, .
[] J. D. Beck, P. Eke, G. Heiss et al., “Periodontal disease and coro-
nary heart disease: a reappraisal of the exposure,” Circulation,
vol. , no. , pp. –, .
[]J.L.Ebersole,M.A.Taubman,D.J.Smith,D.E.Frey,A.D.
Haajee, and S. S. Socransky, “Human serum antibody
responses to oral microorganisms. IV. Correlation with homol-
ogous infection, Oral Microbiology and Immunology,vol.,no.
, pp. –, .
[] D. M. Anderson, J. L. Ebersole, and M. J. Novak, “Functional
properties of nonhuman primate antibody to Porphyromonas
gingivalis,” Infection and Immunity,vol.,no.,pp.,
.
[]P.N.Papapanou,A.M.Neiderud,E.Disick,E.Lalla,G.C.
Miller, and G. Dahl´
en, “Longitudinal stability of serum immu-
noglobulin G responses to periodontal bacteria, Journal of
Clinical Periodontology, vol. , no. , pp. –, .
[] H. J. Shiau and M. A. Reynolds, “Sex dierences in destructive
periodontal disease: exploring the biologic basis, Journal of
Periodontology, vol. , no. , pp. –, .
[] E. N. Fish, “e X-les in immunity: sex-based dierences
predispose immune responses, Nature Reviews Immunology,
vol. , no. , pp. –, .
[] J. L. Rinn and M. Snyder, Sexual dimorphism in mammalian
gene expression, Tren ds in G e net ics ,vol.,no.,pp.,
.
[]S.Paraskevas,J.D.Huizinga,andB.G.Loos,“Asystematic
review and meta-analyses on C-reactive protein in relation to
periodontitis, Journal of Clinical Periodontology,vol.,no.,
pp. –, .
[] R. H. Straub, “e complex role of estrogens in inammation,
Endocrine Reviews, vol. , no. , pp. –, .
[] J. Pfeilschier, R. K¨
oditz, M. Pfohl, and H. Schatz, “Changes in
proinammatory cytokine activity aer menopause, Endocrine
Reviews,vol.,no.,pp.,.
[] C. M. Gameiro, F. Rom˜
ao, and C. Castelo-Branco, Menopause
and aging: changes in the immune system—a review,” Maturi-
tas,vol.,no.,pp.,.
[] D. L. Cochran, “Inammation and bone loss in periodontal
disease, Journal of Periodontolog y,vol.,no.,supplement,
pp.,.
BioMed Research International
[] N. Pischon, N. Heng, J.-P. Bernimoulin, B.-M. Kleber, S. N.
Willich, and T. Pischon, “Obesity, inammation, and periodon-
tal disease, JournalofDentalResearch,vol.,no.,pp.
, .
[] S. Novella, M. Heras, C. Hermenegildo, and A. P. Dantas,
“Eects of estrogen on vascular inammation: a matter of tim-
ing, Arteriosclerosis, rombosis, and Vascular Biology,vol.,
no. , pp. –, .
... In brief, device-treated serum was obtained from a 50-μL sample of whole capillary blood collected from the middle fingertip. The samples of sera were sent immediately to a commercial laboratory (Leisure Inc., Tokyo, Japan) for immune analysis [7,[24][25][26][27]. ...
... Serum IgG antibody titers against periodontal pathogens were determined by Leisure Inc. using enzyme-linked immunosorbent assay (ELISA) [32]. The method and selection of bacterial antigens were based on previous reports [7,[24][25][26][27]. Briefly, sonicated preparations of P. gingivalis FDC381, P. intermedia ATCC25611, and A. actinomycetemcomitans ATCC29523 were used as representative bacterial antigens. ...
Article
Full-text available
Background The diagnosis of the progression of periodontitis presently depends on the use of clinical symptoms (such as attachment loss) and radiographic imaging. The aim of the multicenter study described here was to evaluate the diagnostic use of the bacterial content of subgingival plaque recovered from the deepest pockets in assessing disease progression in chronic periodontitis patients. Methods This study consisted of a 24-month investigation of a total of 163 patients with chronic periodontitis who received trimonthly follow-up care. Subgingival plaque from the deepest pockets was recovered and assessed for bacterial content of Porphyromonas gingivalis, Prevotella intermedia, and Aggregatibacter actinomycetemcomitans using the modified Invader PLUS assay. The corresponding serum IgG titers were measured using ELISA. Changes in clinical parameters were evaluated over the course of 24 months. The sensitivity, specificity, and prediction values were calculated and used to determine cutoff points for prediction of the progression of chronic periodontitis. Results Of the 124 individuals who completed the 24-month monitoring phase, 62 exhibited progression of periodontitis, whereas 62 demonstrated stable disease. The P. gingivalis counts of subgingival plaque from the deepest pockets was significantly associated with the progression of periodontitis (p < 0.001, positive predictive value = 0.708). Conclusions The P. gingivalis counts of subgingival plaque from the deepest pockets may be associated with the progression of periodontitis. Electronic supplementary material The online version of this article (doi:10.1186/s12903-017-0337-x) contains supplementary material, which is available to authorized users.
... In brief, device-treated serum was obtained from a 50-lL sample of whole capillary blood collected from the middle fingertip. The samples of sera were sent immediately to a commercial laboratory (Leisure Inc., Tokyo, Japan) (9,17,23,24). ...
... Serum IgG antibody titers against periodontal pathogens were determined by Leisure Inc., using an ELISA (12). The method and selection of bacterial antigens were based on previous reports (9,17,23,24). Briefly, as representative bacterial antigens, sonicated preparations of P. gingivalis FDC381, P. intermedia ATCC25611 and A. actinomycetemcomitans ATCC29523 were used. ...
Article
Full-text available
Background and objective: A diagnosis of periodontitis progression is presently limited to clinical parameters such as attachment loss and radiographic imaging. The aim of this multicenter study was to monitor disease progression in patients with chronic periodontitis during a 24-mo follow-up program and to evaluate the amount of bacteria in saliva and corresponding IgG titers in serum for determining the diagnostic usefulness of each in indicating disease progression and stability. Material and methods: A total of 163 patients with chronic periodontitis who received trimonthly follow-up care were observed for 24 mo. The clinical parameters and salivary content of Porphyromonas gingivalis, Prevotella intermedia and Aggregatibacter actinomycetemcomitans were assessed using the modified Invader PLUS assay, and the corresponding serum IgG titers were measured using ELISA. The changes through 24 mo were analyzed using cut-off values calculated for each factor. One-way ANOVA or Fisher's exact test was used to perform between-group comparison for the data collected. Diagnostic values were calculated using Fisher's exact test. Results: Of the 124 individuals who completed the 24-mo monitoring phase, 62 exhibited periodontitis progression, whereas 62 demonstrated stable disease. Seven patients withdrew because of acute periodontal abscess. The ratio of P. gingivalis to total bacteria and the combination of P. gingivalis counts and IgG titers against P. gingivalis were significantly related to the progression of periodontitis. The combination of P. gingivalis ratio and P. gingivalis IgG titers was significantly associated with the progression of periodontitis (p = 0.001, sensitivity = 0.339, specificity = 0.790). Conclusions: It is suggested that the combination of P. gingivalis ratio in saliva and serum IgG titers against P. gingivalis may be associated with the progression of periodontitis.
... Lee et al. [26] found that patients with complete compliance had significantly lower rates of tooth loss during supportive periodontal therapy (SPT) than patients with irregular compliance. Moreover, Robinson et al. [27] and Furuta et al. [28] have found that women had a stronger anti-infection ability, healthier oral habits and better overall prognosis of periodontal treatment than that of men [29]. However, in this study, the factors of age and gender showed no significant correlation, which may be related to the limited sample size. ...
Article
Full-text available
Abstract Background This study is aimed to analyze the prognostic factors affecting the short-term efficacy of non-surgical treatment of patients in periodontitis from stage II to stage IV by the multilevel modeling analysis. Materials and methods A total of 58 patients with chronic periodontitis were included in this study. Patients were clinically explored before and 3 months after the treatment and the difference in probing depth was determined [Reduction of probing depth (Δ PD) = baseline PD – finial probing depth (FPD)] which is considered as the therapeutic evaluation. Three different levels were analyzed: patients, teeth and sites to construct a multi-layer linear model. Results Probing depth (PD) improved significantly compared with that before treatment (p
... Lee et al. [26] found that patients with complete compliance had signi cantly lower rates of tooth loss during supportive periodontal therapy (SPT) than patients with irregular compliance. Moreover, Robinson et al. [27] and Furuta et al. [28] have found that women had a stronger anti-infection ability, and the oral health habits of women were better than men, and the overall prognosis of periodontal treatment of women was better than that of men [29]. However, in this study, the factors of age and gender showed no signi cant correlation, which may be related to the limited sample size. ...
Preprint
Full-text available
Background: This current study is aimed to analyze the prognostic factors affecting the short-term efficacy of non-surgical treatment of patients in periodontitis from stage Ⅱ to stage Ⅳ by the multilevel modelling analysis. Materials and Methods: A total of 58 patients with chronic periodontitis were included in this study. Patients were clinically explored before and 3 months after the treatment and the difference in probing depth was determined [ Reduction of probing depth (Δ PD) = baseline PD - finial probing depth (FPD)]. Three different levels were analyzed: patients, teeth and sites to construct a multi-layer linear model. Results: Probing depth (PD) improved significantly compared with that before treatment (p < 0.05), in which FPD was (3.90±1.39) mm, and the ΔPD was (1.79±0.97) mm. Compared with the mesial sites and distal sites of the multi-rooted teeth, the number of PD ≥ 5mm or PD < 5mm after the treatment was significantly different (P < 0.05), and the proportion of PD < 5mm was higher in mesial sites. The null model showed that Δ PD varied greatly between groups at various levels (P <0.001), with prediction variable of site level, tooth level, and patient level accounted for 66%, 18%, and 16% of the overall difference, respectively. The complete model showed that the Δ PD of smokers was significantly lower than that of non-smokers (P < 0.001). The Δ PD of the mesial and distal sites was larger than that of the buccolingual central site (P < 0.001). The Δ PD of single-rooted teeth was larger than that of multi-rooted teeth (P < 0.001). The baseline PD, tooth mobility (TM), bleeding index (BI), clinical attachment loss (CAL) were significantly negatively correlated with Δ PD (P < 0.001). Conclusions: Patients with periodontitis from stage Ⅱ to stage Ⅳ, who are non-smoking, have good compliance, good awareness of oral health, and low percentage sites with PD ≥ 5mm at baseline, single rooted teeth with hypomobility, less clinical attachment loss and lower bleeding index and sites of mesial or distal can obtain an ideal short-term efficacy of non-surgical treatment.
... Lee et al. [20] found that patients with complete compliance had significantly lower rates of tooth loss during supportive periodontal therapy (SPT) than the patients with irregular compliance. Moreover, Robinson et al. [21] and Furuta et al. [22] have found that women had stronger anti-infection ability, and the oral health habits of women were better than men, and the overall prognosis of periodontal treatment of women was better than that of men [23]. However, in this study, the factors of age and gender showed no significant correlation, which may be related to the limited sample size. ...
Preprint
Full-text available
Objective This current study is aimed to analyze the prognostic factors affecting the short-term efficacy of non-surgical treatment of patients in periodontitis from stage II to stage IV by the multilevel modelling analysis. Materials and Methods A total of 58 patients of chronic periodontitis were included in this study. Patients were clinically explored before and 3 months after the treatment, with the data of Δ probing depth (PD) [Δ PD = baseline PD – finial probing depth (FPD)] as the outcome variables. All the data were divided into site level, tooth level and patient level to construct a multi-layer linear model. Results Compared with the mesial sites and distal sites of the multi-rooted teeth, the number of PD ≥ 5mm or PD < 5mm after the treatment was significantly different ( P < 0.05), and the proportion of PD < 5mm was higher in mesial sites. The null model showed that Δ PD varied greatly between groups at various levels ( P <0.001), with prediction variable of site level, tooth level, and patient level accounted for 66%, 18%, and 16% of the overall difference, respectively. The complete model showed that the Δ PD of smokers was significantly lower than that of non-smokers ( P < 0.001). The Δ PD of the mesial and distal sites was larger than that of the buccolingual central site ( P < 0.001). The Δ PD of single-rooted teeth was larger than that of multi-rooted teeth ( P < 0.001). The baseline PD, tooth mobility (TM), bleeding index (BI), clinical attachment loss (CAL) were significantly negatively correlated with Δ PD ( P < 0.001). Conclusions Patients with periodontitis from stage II to stage IV, who are non-smoking, have good compliance, good awareness of oral health, and low percentage sites with PD ≥ 5mm at baseline, single rooted teeth with hypomobility, less CAL and lower BI and sites of mesial or distal can obtain an ideal short-term efficacy of non-surgical treatment.
... In fact, in an effort to apply the above basic principles to the periodontal hypothesis, limited clinical experimental data have supported a higher concentration of the IgG antibody against Porphyromonas gingivalis in women than men, similar to chronic periodontitis (58). In summary, given that the innate immune response might be more regulated in women (53) and more intense in men, women tend to be more effective at pathogen clearance compared to men. ...
Article
Full-text available
Periodontitis, a complex polymicrobial inflammatory disease, is a public health burden affecting more than 100 million people and being partially responsible for tooth loss. Interestingly, periodontitis has a documented higher prevalence in men as compared to women signifying a possible sex/gender entanglement in the disease pathogenesis. Although relevant evidence has treated sex/gender in a simplistic dichotomous manner, periodontitis may represent a complex inflammatory disease model, in which sex biology may interfere with gender social and behavioral constructs affecting disease clinical phenotype. Even when it became clear that experimental oral health research needed to incorporate gender (and/or sex) framework in the hypothesis, researchers overwhelmingly ignored it unless the research question was directly related to reproductive system or sex-specific cancer. With the recognition of gender medicine as an independent field of research, this study challenged the current notion regarding sex/gender roles in periodontal disease. We aimed to develop the methodological and analytical framework with the recognition of sex/gender as important determinants of disease pathogenesis that require special attention. First, we aim to present relevant sex biologic evidence to understand the plausibility of the epidemiologic data. In periodontitis pathogenesis, sex dimorphism has been implicated in the disease etiology possibly affecting the bacterial component and the host immune response both in the innate and adaptive levels. With the clear distinction between sex and gender, gender oral health disparities have been explained by socioeconomic factors, cultural attitudes as well as access to preventive and regular care. Economic inequality and hardship for women have resulted in limited access to oral care. As a result, gender emerged as a complex socioeconomic and behavioral factor influencing oral health outcomes. Taken together, as disease phenotypic presentation is a multifactorial product of biology, behavior and the environment, sex dimorphism in immunity as well as gender socio-behavioral construct might play a role in the above model. Therefore, this paper will provide the conceptual framework and principles intergrading sex and gender within periodontal research in a complex biologic and socio-behavioral dimension.
Article
Aging humans display an increased prevalence and severity of periodontitis, although the mechanisms underlying these findings remain poorly understood. This report examined antigenic diversity of P. gingivalis related to disease presence and patient demographics. Serum IgG antibody to P. gingivalis strains ATCC33277, FDC381, W50 (ATCC53978), W83, A7A1-28 (ATCC53977) and A7436 was measured in 426 participants [periodontally healthy (n = 61), gingivitis (N = 66) or various levels of periodontitis (N = 299)]. We hypothesized that antigenic diversity in P. gingivalis could contribute to a lack of "immunity" in the chronic infections of periodontal disease. Across the strains, the antibody levels in the oldest age group were lower than in the youngest groups, and severe periodontitis patients did not show higher antibody with aging. While 80% of the periodontitis patients in any age group showed an elevated response to at least one of the P. gingivalis strains, the patterns of individual responses in the older group were also substantially different than the other age groups. Significantly greater numbers of older patients showed strain-specific antibody profiles to only 1 strain. The findings support that P. gingivalis may demonstrate antigenic diversity/drift within patients and could be one factor to help explain the inefficiency/ineffectiveness of the adaptive immune response in managing the infection.
Article
Full-text available
Periodontal disease and metabolic syndrome (MS) are more prevalent in males than in females. However, whether there is a gender difference in the association between these health conditions has not yet been investigated. This study examined the gender difference in this association, considering the definition of periodontal disease. We recruited 1040 males and 1330 females, aged ≥40 years, with at least ten teeth from subjects of the 2007 Hisayama health examination. We performed a logistic regression analysis with various definitions of periodontal disease the dependent variable and MS as the independent variable. Following the analysis, the data were reanalysed with the structural equations model. The logistic regression analysis suggested a stronger association between periodontal disease and MS in females than that in males when periodontal disease was more severely defined. When we constructed the structural equations model in each gender, the model showed a good fit to the data of females, suggesting the association between periodontal disease and MS in females, but not in males. Gender differences seem to exist in the association between periodontal disease and MS; MS might show a stronger association with periodontal disease in females than in males.
Article
Full-text available
Chronic periodontitis is a silent infectious disease prevalent worldwide and affects lifestyle-related diseases. Therefore, efficient screening of patients is essential for general health. This study was performed to evaluate prospectively the diagnostic utility of a blood IgG antibody titer test against periodontal pathogens. Oral examination was performed, and IgG titers against periodontal pathogens were measured by ELISA in 1,387 individuals. The cut-off value of the IgG titer was determined in receiver operating characteristic curve analysis, and changes in periodontal clinical parameters and IgG titers by periodontal treatment were evaluated. The relationships between IgG titers and severity of periodontitis were analyzed. The best cut-off value of IgG titer against Porphyromonas gingivalis for screening periodontitis was 1.682. Both clinical parameters and IgG titers decreased significantly under periodontal treatment. IgG titers of periodontitis patients were significantly higher than those of healthy controls, especially in those with sites of probing pocket depth over 4 mm. Multiplied cut-off values were useful to select patients with severe periodontitis. A blood IgG antibody titer test for Porphyromonas gingivalis is useful to screen hitherto chronic periodontitis patients (ClinicalTrials.gov number NCT01658475).
Article
Full-text available
Our study aims to determine the role of time of menopause on vascular inflammation biomarkers and how it affects their modulation by estrogen and raloxifene in postmenopausal women. Uterine arteries from 68 postmenopausal women were divided into 3 segments and cultured for 24 hours in tissue culture media containing 17β-estradiol (100 nmol/L), raloxifene (100 nmol/L), or vehicle. Assessment of arterial concentration of 13 inflammatory biomarkers was performed by multiplex immunobead-based assay. Aging per se has a positive correlation with the generation of several proinflammatory markers. Although short-term estradiol exposure correlates with lower expression of tumor necrosis factor-α, vascular endothelial growth factor, and interleukin-1β in all age groups, for most biomarkers aging was associated with a switch from a beneficial anti-inflammatory action by estrogen, at earlier stages of menopause, to a proinflammatory profile after 5 years past its onset. Raloxifene has no significant effect on the expression of all proinflammatory markers. Western blot analysis of estrogen receptor expression (estrogen receptor-α and estrogen receptor-β) showed that estrogen receptor-β increases with aging, and this increase has a positive correlation with the generation of several proinflammatory markers. Aging alters estrogen-mediated effects on the modulation of inflammatory biomarkers in women. How aging affects estrogen responses on vascular inflammation is not clear, but our data show a positive association between increased estrogen receptor-β expression with aging and proinflammatory effects by estrogen.
Conference Paper
PERIODONTAL DISEASES ARE INFECTIONS, and many forms of the disease are associated with specific pathogenic bacteria which colonize the subgingival area. At least two of these microorganisms, Porphyromonas gingivalis and Actinobacillus actinomycetemcomitans, also invade the periodontal tissue and are virulent organisms. Initiation and progression of periodontal infections are clearly modified by local and systemic conditions called risk factors. The local factors include pre-existing disease as evidenced by deep probing depths and plaque retention areas associated with defective restorations. Systemic risk factors recently have been identified by large epidemiologic studies using multifactorial statistical analyses to correct for confounding or associated co-risk factors, Risk factors which we know today as important include diabetes mellitus, especially in individuals in whom metabolic control is poor, and cigarette smoking. These two risk factors markedly affect the initiation and progression of periodontitis, and attempts to manage these factors are now an important component of prevention and treatment of adult periodontitis. Systemic conditions associated with reduced neutrophil numbers or function are also important risk factors in children, juveniles, and young adults. Diseases in which neutrophil dysfunction occurs include the lazy leukocyte syndrome associated with localized juvenile periodontitis, cyclic neutropenia, and congenital neutropenia. Recent studies also point to several potentially important periodontal risk indicators. These include stress and coping behaviors, and osteopenia associated with estrogen deficiency. There are also background determinants associated with periodontal disease including gender (with males having more disease), age (with more disease seen in the elderly), and hereditary factors. The study of risk in periodontal disease is a rapidly emerging field and much is yet to be learned. However, there are at least two significant risk factors-smoking and diabetes-which demand attention in current management of periodontal disease.
Article
The aim of this review is to summarize present evidence of an association between circulating levels of C-reactive protein (CRP) and cancer risk, and to evaluate whether elevated circulating CRP levels cause cancer. Additionally, the review provides background information on the acute-phase response, chronic inflammation, the molecular biology, function and measurement of CRP, circulating levels of CRP in health and disease, the principle of Mendelian randomization, the association between circulating levels of CRP and cancer prognosis, and cancer biomarkers. In the Copenhagen General Population Study of approximately 63,500 individuals, the distribution of circulating levels of CRP was markedly skewed to the right with 97% of the participants having CRP levels<10 mg/L. The median plasma CRP concentration was 1.53 mg/L (IQR, 1.14-2.51) and 34% of the participants had circulating CRP levels of ≥2 mg/L. Epidemiologic studies suggest that in patients with several types of solid cancers, elevated circulating levels of CRP are associated with poor prognosis, whereas in apparently healthy individuals from the general population, elevated levels of CRP are associated with increased future risk of cancer of any type, lung cancer, and possibly colorectal cancer, but not breast or prostate cancer. The robust association between circulating levels of CRP and cancer risk may be due to (1) causality: elevated CRP levels cause cancer, (2) reverse causality: occult cancer increases CRP levels, (3) or confounding: a third factor, e.g. inflammation, increases both CRP levels and the risk of cancer. Genetic epidemiologic studies (Mendelian randomization studies), which have examined the association between genetic polymorphisms influencing circulating levels of CRP and cancer risk suggest that circulating levels of CRP do not cause cancer. A lack of causality between elevated CRP levels and increased cancer risk does, however, not invalidate the potential clinical use of slightly increased CRP levels to predict risk of certain cancer types, and to improve staging and treatment allocation in patients diagnosed with cancer. Indeed, in a study of the general population, individuals with CRP levels in the highest versus the lowest quintile had a 1.3-fold increased risk of cancer of any type and a 2-fold increased risk of lung cancer. Among individuals diagnosed with cancer during the study period, individuals with a high baseline CRP (>3 mg/L) had an 80% greater risk of early death compared with those with low CRP levels (<1 mg/L). Accordingly, patients with invasive breast cancer and CRP levels>3 mg/L at diagnosis had a 1.7-fold increased risk of death from breast cancer compared to patients with CRP levels<1 mg/L at diagnosis.